Talk SCOPE Biotech Forum track
Why Can’t We Solve Underrepresentation in Our Clinical Trials?
Tue, Mar 2, 2027 · 11:05–11:30 AM EST Rosen Shingle Creek
About this session
For years, the industry has attempted to solve the complex problem of underrepresentation in groups of people who are disproportionately burdened by some diseases. We also continue to seek the barriers. In this session, we will discuss some new ideas being piloted to solve complex issues of underrepresentation in trials and ways to build community relationships with promise, offer solutions for self-sustaining infrastructure, and consider how we may partner with other sponsors in a pre-competitive way.
